Uncommon Therapeutics
A Disease Focused Biotech, Building Multiple Billion Dollar Drugs
About Uncommon Therapeutics
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.
Company details
Funding
Total raised
$500K
Last stage
Pre-seed
Investors
Founders
Ryan Lim
Biotech entrepreneur and biomedical scientist specializing in modeling neurological disorders using stem cells, in vivo models, and computational biology to drive breakthroughs in neurological diseases
LinkedIn
Noah Auerhahn
Serial tech entrepreneur; bootstrapped first company and sold to Rakuten for $15M; raised over $75M for second venture (Robin Healthcare). Pivoted to biotech after his daughter was diagnosed with Rett Syndrome in 2021.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.